title: Risks and benefits of phase 1 clinical trials evaluating new anticancer agents: a case for more innovation.
authors.forename: Eric X
authors.initials: EX
authors.lastname: Chen
authors.forename: Ian F
authors.initials: IF
authors.lastname: Tannock
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic / Q000592:standards; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D012306:Risk; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents